AcuityMD, the AI platform for MedTech, today announced $80 million in new funding to elevate its platform with advanced artificial intelligence (AI) capabilities and drive the company's mission of ...

AcuityMD has raised $80 million to add artificial intelligence features to its platform for medical device commercial teams.

Nucleus plans to expand capabilities at Rochester facility and finish construction of new site near Philadelphia.

Development teams that benefit most from high-resolution additive manufacturing are using it to ask better questions earlier ...

AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) ...

The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next ...

AcuityMD announced today that it secured $80 million in a Series C funding round to support its AI-powered platform.

Former Align Technology CEO brings proven U.S. medtech scale-up experience as Nutromics advances toward 2027 commercial ...

Johnson & Johnson MedTech reported 4.6% growth in Q1, driven by a strong pipeline of cardiovascular and surgical innovations.

The U.S. Food and Drug Administration (FDA) has launched the Reducing Readmissions through Device Innovation for the Home (READI-Home) Innovation Challenge to accelerate patient access to medical devi ...

White Brook Capital Partners, an investment management firm, released its first-quarter 2026 investor letter. A copy of the ...